Efectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine and lamivudine in HIV-1-infected adults in Cameroon: Open-label multicentre trial. Laurent C, Kovanfack C, Koulla-Shiro S, Nikové N et al. Lancet 2004; 364: 29-34

Guardado en:
Detalles Bibliográficos
Autor principal: Calvo A.,Mario
Lenguaje:Spanish / Castilian
Publicado: Sociedad Chilena de Infectología 2004
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-10182004000400013
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0716-10182004000400013
record_format dspace
spelling oai:scielo:S0716-101820040004000132005-04-14Efectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine and lamivudine in HIV-1-infected adults in Cameroon: Open-label multicentre trial. Laurent C, Kovanfack C, Koulla-Shiro S, Nikové N et al. Lancet 2004; 364: 29-34Calvo A.,Marioinfo:eu-repo/semantics/openAccessSociedad Chilena de InfectologíaRevista chilena de infectología v.21 n.4 20042004-12-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-10182004000400013es10.4067/S0716-10182004000400013
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
author Calvo A.,Mario
spellingShingle Calvo A.,Mario
Efectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine and lamivudine in HIV-1-infected adults in Cameroon: Open-label multicentre trial. Laurent C, Kovanfack C, Koulla-Shiro S, Nikové N et al. Lancet 2004; 364: 29-34
author_facet Calvo A.,Mario
author_sort Calvo A.,Mario
title Efectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine and lamivudine in HIV-1-infected adults in Cameroon: Open-label multicentre trial. Laurent C, Kovanfack C, Koulla-Shiro S, Nikové N et al. Lancet 2004; 364: 29-34
title_short Efectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine and lamivudine in HIV-1-infected adults in Cameroon: Open-label multicentre trial. Laurent C, Kovanfack C, Koulla-Shiro S, Nikové N et al. Lancet 2004; 364: 29-34
title_full Efectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine and lamivudine in HIV-1-infected adults in Cameroon: Open-label multicentre trial. Laurent C, Kovanfack C, Koulla-Shiro S, Nikové N et al. Lancet 2004; 364: 29-34
title_fullStr Efectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine and lamivudine in HIV-1-infected adults in Cameroon: Open-label multicentre trial. Laurent C, Kovanfack C, Koulla-Shiro S, Nikové N et al. Lancet 2004; 364: 29-34
title_full_unstemmed Efectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine and lamivudine in HIV-1-infected adults in Cameroon: Open-label multicentre trial. Laurent C, Kovanfack C, Koulla-Shiro S, Nikové N et al. Lancet 2004; 364: 29-34
title_sort efectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine and lamivudine in hiv-1-infected adults in cameroon: open-label multicentre trial. laurent c, kovanfack c, koulla-shiro s, nikové n et al. lancet 2004; 364: 29-34
publisher Sociedad Chilena de Infectología
publishDate 2004
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-10182004000400013
work_keys_str_mv AT calvoamario efectivenessandsafetyofagenericfixeddosecombinationofnevirapinestavudineandlamivudineinhiv1infectedadultsincameroonopenlabelmulticentretriallaurentckovanfackckoullashirosnikovenetallancet20043642934
_version_ 1718440067094020096